Confidential regulatory matters

Discuss your FDA or pharmaceutical quality matter.

Provide only the information necessary to help us understand the nature and urgency of the issue. A mutual confidentiality agreement can be executed before substantive confidential information is exchanged.

Prepare an inquiry

This form does not send anything by itself. It prepares your message; you send it from your own email application.

NameCompanyEmailPhone (optional)Type of issueUrgencyInspection statusShort descriptionFDA is currently onsite.

Nothing entered here is stored by this website, and nothing is sent automatically. Your inquiry is received only when your email arrives at jlambert@tailwindconsult.com.

Prefer to talk first? Book the 15-minute discussion on the left.